释义 |
risperidone 英ris'pəridʌn美ris'pəridʌn COCA²⁸⁰¹³⁶⁺⁵iWeb⁴⁴²⁷⁰ 基本例句 n.【医】利哌利酮,利哌酮抗精神失常药 The incidences of extra- pyramidal symptoms and endocrine change in Risperidone group were obviously higher than those in Aripiprazole group P0.05. 利培酮组锥体外系不良反应和内分泌改变的发生均明显高于阿立呱唑组 P均0.05。 cnki The incidence of untoward reaction in Aripiprazole group was lower than that in Risperidone group and the difference was significant P0.05. 阿立呱唑组的不良反应发生率低于利培酮组,有显著性差异 P0.05。 cnki But the risperidone and olanzapine caused serious weight gain. 但是利哌酮或奥氮平引起体重大幅增加。 hjenglish Conclusion: Risperidone appears to be more safety and stable effect in treatment of schizophrenia, it is good for patients to return to the society. 结论利培酮治疗精神分裂症远期疗效稳定,安全性高,有利于患者重返社会。 cnki Conclusion: Risperidone is safer than chlorpromazine as for its damage to heart. 结论:利培酮对心脏损害小,安全度高。 cnki Conclusion Clozapine leads to gain weight easily, Risperidone has a less influence on body weight. 结论氯氮平易导致病人体重增加,利培酮对体重的影响较轻。 cnki First order derivative UV spectrophotometry was applied for determination of risperidone tablets. 采用一阶导数分光光度法测定利培酮片的含量。 cnki Method48 schizophrenic patients were divided into3 groups, with treatment of clozapine, risperidone and quetiapine respectively for8 weeks. 方法将48例首发精神分裂症患者分为3组,并分别单用氯氮平、利培酮、奎硫平治疗8周。 chemyq Most subjects in the study received risperidone, while the rest received other second-generation antipsychotic medications. 在这些研究中大多数的被试者已接受利培酮治疗,其余患者接受了第二代抗精神病药物治疗。 yeeyan Neurocognitive improvement after18 months of treatment was greater in the perphenazine group than in the olanzapine and risperidone groups. 奋乃静组与奥氮平组、利培酮组相比,在治疗18个月后,神经认知改善明显较大。 dxy Objective To survey the value of risperidone in the treatment of depression without psychotic symptoms. 目的评价利培酮在治疗无精神病性症状抑郁症中的地位。 dictall Objective To compare the efficacy and safety of risperidone or clozapine both combined with lithium in acute mania. 目的比较利培酮和氯氮平分别合并碳酸锂治疗急性躁狂的疗效和安全性。 cnki Objective To compared chlorpromazine with risperidone effect on body posture balance. 目的比较氯丙嗪与利培酮对人体姿态平衡的效应。 cnki Objective To discuss the clinical efficacy and safety of Risperidone Oral Solution in the treatment of the excitement and agitation in acute phase of schizophrenia. 目的探讨利培酮口服液治疗精神分裂症急性期兴奋激越的临床疗效与安全性。 dictall Objective To evaluate the efficacy and the safety of risperidone and haloperidol in treatment of senile mental disorder. 目的比较利培酮和氟哌啶醇治疗老年期精神障碍的疗效和安全性。 cnki Objective To evaluate the efficacy and safety of risperidone and haloperidol in treating manic episodes of bipolar disorder. 目的比较利培酮与氟哌啶醇治疗双相躁狂的疗效和安全性。 cnki Objective To investigate the effect of risperidone combined with mental and behavioral therapy on the negative symptoms of Schizophrenia. 目的探讨心理与行为治疗合并利培酮对精神分裂症阴性症状的治疗康复作用。 cnki Objective To investigate the efficacy of Risperidone combined with Depakine for schizophrenia accompanied by psychomotor excitement symptoms. 目的观察利培酮联合德巴金治疗伴精神运动性兴奋的精神分裂症的效果。 dictall Objective To study the pathogenic mechanism and the treatment of acute risperidone poisoning. 目的探讨急性利培酮中毒的发病机制和治疗措施。 chemyq Objective:To compare the efficacy and side effects of risperidone and perphenazine in the treatment of elderly brain organic mental disorders. 目的:比较利培酮与奋乃静治疗老年器质性精神障碍的疗效及不良反应。 cnki Objective:To compare the therapeutic and side effects of risperidone and haloperidol in the treatment of child schizophrenia. 目的:比较利培酮和氟哌啶醇治疗儿童精神分裂症的疗效和不良反应。 cnki Results: There were significant differences in the blood prolactin and body index after treatment between aripiprazole and risperidone groups. 结果:阿立派唑与利培酮对女性患者血清催乳素、体型指数的影响有显著差异。 cnki Small but statistically significant evidence was found for effectiveness of aripiprazole, olanzapine, and risperidone in the treatment of dementia. 少数但是有显著统计学意义的证据表明阿立哌唑、奥氮平和利培酮对痴呆的治疗有效。 yeeyan The recommended starting dose for long-acting risperidone is25 mg delivered by intramuscular injection every2 weeks. 长效利培酮针剂的推荐起始剂量为25mg,每两周通过肌注给药。 yeeyan The study defined mild nonadherence as“compliance with 50 percent-75 percent of the prescribed oral risperidone dose for at least two consecutive weeks during the18- month follow-up period.” 此研究定义轻度的不依从为“在18个月的追踪访问周期中,仅按照50%-75%的处方剂量口服利培酮至少连续两周。” yeeyan Risperidone group reported significantly less side effect than haloperidol group. 利培酮组不良反应发生率比氟哌啶醇组明显为低。 cnki Risperidone long-acting injection is available in dosage strengths of12.5 mg, 25 mg,37.5 mg, or50 mg and previously was approved for the treatment of schizophrenia. 利培酮长效针剂现有剂型为12.5 mg、25mg、37.5 mg或50mg。它在治疗精神分裂症上早已获得批准。 yeeyan |